Ethyl 4-carbamoyl-5-(2-chloroacetamido)-2-methylfuran-3-carboxylate

Catalog No.: 
ACDCJB161
CAS No.: 
874754-21-9
Molecular Formula: 
C11H13ClN2O5
Molecular Weight: 
288.69
Ethyl 4-carbamoyl-5-(2-chloroacetamido)-2-methylfuran-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$113.00InquiryInquiry
100mg95%$159.00InquiryInquiry
250mg95%$219.00InquiryInquiry
1g95%$535.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 4-carbamoyl-5-(2-chloroacetamido)-2-methylfuran-3-carboxylate
IUPAC Nameethyl 4-carbamoyl-5-(2-chloroacetamido)-2-methylfuran-3-carboxylate
MDL No.MFCD07689451
Molecular FormulaC11H13ClN2O5
Molecular Weight288.69
SMILESO=C(C1=C(C)OC(NC(CCl)=O)=C1C(N)=O)OCC
InChI KeyUOFLJWNRFMTFIH-UHFFFAOYSA-N
Synonym3-Furancarboxylic acid, 4-(aminocarbonyl)-5-[(2-chloroacetyl)amino]-2-methyl-, ethyl ester;Ethyl 4-Carbamoyl-5-(2-chloroacetamido)-2-methylfuran-3-carboxylate
CAS No.874754-21-9

Synthetic Route by SureRoute

1. ACDCJB161 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDCJB161 route product structure diagram
    ACDCJB161874754-21-9
Inquiry

2. ACDCJB161 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDCJB161 route product structure diagram
    ACDCJB161874754-21-9
Inquiry

3. ACDCJB161 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDCJB161 route product structure diagram
    ACDCJB161874754-21-9
Inquiry

Comments (0)